PORTLAND, Ore., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aronora, a clinical-stage biopharmaceutical company pioneering innovative therapies for cardio-hematologic diseases, today announced the expansion of ...

Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on small-molecule inhibition of CLK/DYRK kinases, announced today that ...

After two decades of surgeries, prescriptions, and debilitating symptoms, this mom discovered a treatment that significantly ...

The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.

Cells have a remarkable housekeeping system: proteins that are no longer needed, defective, or potentially harmful are labeled with a molecular "tag" and dismantled in the cellular recycling machinery ...

A major goal of structural and functional genomics (or proteomics) is to deduce the structure and function of novel proteins by finding sequence homologies to biochemically well-characterized proteins ...

Asia-Pacific's penicillin G acylase market surges on China's Shandong mega-scale (60% global 6-APA) and India's PLI ramps ...

The "SYK Inhibitors Market, Drug Price, Sales & Clinical Trials Outlook 2030" report has been added to ResearchAndMarkets.com's offering. Report Findings & Highlights: Global SYK Inhibitor Market ...

Alumis Inc. surged on Phase 3 psoriasis data for envudeucitinib. Click for this look at ALMS stock and why I am bullish on ...

Discover the 9 best face washes for aging skin we tried in 2025 — tested and reviewed with dermatologist expertise.